Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

IBRXIBRX
7 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in IMMUNITYBIO INC

ROYAL BANK OF CANADA holds 1.5M shares of IBRX (IMMUNITYBIO INC), worth $13.5M as of 2026-Q2. The position was increased (+3.8% shares). IBRX represents 0.0% of ROYAL BANK OF CANADA's portfolio.

Current Value

$13.5M

Current Shares

1.5M

Total Value Change

+$13.2M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+3.8%
$13.5M0.0%$8.76
29
2026-Q1
Increased
1.5M
+1731.8%
$11.4M0.0%$10.00
45
2025-Q4
Decreased
81,127
-90.8%
$162,0000.0%$1.98
0
2025-Q3
Decreased
880,378
-64.1%
$2.2M0.0%$2.57
0
2025-Q2
Increased
2.5M
+4193.0%
$6.5M0.0%$2.70
44
2025-Q1
Decreased
57,073
-45.0%
$172,0000.0%$3.14
0
2024-Q4
New
103,757
-
$266,0000.0%$2.68
32

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used